{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:16:07Z","timestamp":1774124167392,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.transproceed.2006.12.023","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T07:33:03Z","timestamp":1176881583000},"page":"594-595","source":"Crossref","is-referenced-by-count":14,"title":["Case Report of a Kidney Transplant Recipient Converted to Everolimus Due to Malignancy: Resolution of Bronchiolitis Obliterans Organizing Pneumonia Without Everolimus Discontinuation"],"prefix":"10.1016","volume":"39","author":[{"given":"C. Agost","family":"Carre\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gadea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2006.12.023_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1523-1755.2004.00741.x","article-title":"Risk of malignancy with long-term immunosuppression in renal transplant recipients","volume":"66","author":"Agrahakar","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2006.12.023_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.critrevonc.2004.11.010","article-title":"Cancer incidence after immunosuppressive treatment following kidney transplantation","volume":"56","author":"Andres","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.transproceed.2006.12.023_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1681\/ASN.2005090993","article-title":"Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation","volume":"17","author":"Campistol","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2006.12.023_bib4","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi\u2019s sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2006.12.023_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/10408360091174204","article-title":"The role of human papillomavirus in gynecological diseases","volume":"37","author":"Nuovo","year":"2000","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.transproceed.2006.12.023_bib6","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1158\/1078-0432.CCR-06-0764","article-title":"Phase I\/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies","volume":"12","author":"Yee","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.transproceed.2006.12.023_bib7","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1053\/j.seminoncol.2006.03.024","article-title":"Future directions in the treatment of hormone sensitive advanced breast cancer: the RAD 001 (everolimus)-letrozole clinical program","volume":"33","author":"Lane","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.transproceed.2006.12.023_bib8","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/01.mlg.0000210544.64659.35","article-title":"Everolimus (RAD) inhibits in vivo growth of murine squamous cell carcinoma (SCC VII)","volume":"116","author":"Khariwala","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.transproceed.2006.12.023_bib9","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1600-6143.2006.01412.x","article-title":"Sirolimus conversion for patients with Kaposi sarcoma","volume":"6","author":"Lebb\u00e9","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2006.12.023_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1600-6135.2003.00292.x","article-title":"Sirolimus induced pneumonitis: three cases and a review of the literature","volume":"4","author":"Haydar","year":"2004","journal-title":"Am J Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134506015703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134506015703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T23:51:52Z","timestamp":1546905112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134506015703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0041134506015703"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2006.12.023","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1082791.535713","asserted-by":"object"}]},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}